Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-26T07:37:44.641Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic malignant syndrome

Published online by Cambridge University Press:  02 January 2018

J.G. Longhurst
J.G. Longhurst*
Affiliation:
Yale University School of Medicine, 611 Grace Education Building, 25 Park Street, New Haven, Connecticut 06519
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 166 , Issue 4 , April 1995 , pp. 537 - 538
Copyright
Copyright © Royal College of Psychiatrists, 1995 

References

Ayd, F. J. (1956) Fatal hyperpyrexia during chlorpromazine therapy. Journal of Clinical Psychiatry, 27, 189–192.Google Scholar
Friccione, G. L. (1985) Neuroleptic catatonia and its relationship to psychogenic catatonia. Biological Psychiatry, 20, 304–313.Google Scholar
Friedhoff, A. J. (1983) A strategy for developing novel drugs for the treatment of schizophrenia. Schizophrenia Bulletin, 9, 555–562.Google Scholar
Lindesay, J. (1986) Neuroleptic malignant syndrome and lethal catatonia. British Journal of Psychiatry, 148, 342–343.Google Scholar
Redlich, F. C. & Friedman, D. X. (1966) The Theory and Practice of Psychiatry. New York: Basic Books.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.